FDA Approves Syfovre (pegcetacoplan injection) for the Treatment of Geographic Atrophy, a Leading Cause of Blindness
WALTHAM, Mass., Feb. 17, 2023 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader in complement, today announced that the U.S. Food and Drug Administration (FDA) has approved Syfovre™... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - February 17, 2023 Category: Drugs & Pharmacology Source Type: news
New phase III data show Roche ’s Vabysmo rapidly improved vision and reduced retinal fluid in people with retinal vein occlusion (RVO)
Vabysmo met its primary endpoint in two clinical trials, BALATON and COMINO, showing non-inferior visual acuity gains compared toafliberceptMoreVabysmo patients showed an absence of blood vessel leakage in the retina compared toaflibercept in a pre-specified exploratory endpointIf approved, RVO would be the third indication forVabysmo in addition toneovascular or ‘wet’ age-related macular degeneration and diabetic macular edemaBasel, 10 February 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced positive new data from two global phase III studies, BALATON and COMINO, evaluating Vabysmo ® (faricimab) in macular ...
Source: Roche Investor Update - February 10, 2023 Category: Pharmaceuticals Source Type: news
New phase III data show Roche ’s Vabysmo rapidly improved vision and reduced retinal fluid in people with retinal vein occlusion (RVO)
Vabysmo met its primary endpoint in two clinical trials, BALATON and COMINO, showing non-inferior visual acuity gains compared toafliberceptMoreVabysmo patients showed an absence of blood vessel leakage in the retina compared toaflibercept in a pre-specified exploratory endpointIf approved, RVO would be the third indication forVabysmo in addition toneovascular or ‘wet’ age-related macular degeneration and diabetic macular edemaBasel, 10 February 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced positive new data from two global phase III studies, BALATON and COMINO, evaluating Vabysmo ® (faricimab) in macular ...
Source: Roche Media News - February 10, 2023 Category: Pharmaceuticals Source Type: news
Eylea (aflibercept) Injection Approved as the First Pharmacologic Treatment for Preterm Infants with Retinopathy of Prematurity (ROP) by the FDA
ROP is a leading cause of childhood blindness worldwide
Eylea now approved to treat five retinal conditions caused by ocular angiogenesis
TARRYTOWN, N.Y., Feb. 08, 2023 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN)... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - February 8, 2023 Category: Drugs & Pharmacology Source Type: news
Death, blindness, eye drops recall: bacterial infections in Florida, Texas, other states
(Source: Reuters: Health)
Source: Reuters: Health - February 5, 2023 Category: Consumer Health News Source Type: news
Announcing February 2023 NNLM Reading Club: Eyes and Vision
February is Low Vision Month. “You’re either kind of a super blind person or you’re kind of on the other end of the spectrum, kind of a pitiable blind person, and a lot of what I try and do in the book is kind of looking at the middle, you know, the vast middle ground of most of us who are just living our lives, you know, as mothers and people who work and teach and all those sorts of things.” – M. Leona Godin, author of February featured book “There Plant Eyes: A Personal and Cultural history of Blindness” from Blind Abilities podcast
This February, we turn our attention to the importance of learning mor...
Source: The Cornflower - February 2, 2023 Category: Databases & Libraries Authors: Darlene Kaskie Tags: NNLM Reading Club Source Type: news
Recognizing National Glaucoma Awareness Month
January was National Glaucoma Awareness Month and provided us an opportunity to spread the word and honor the millions of patients around the world who are impacted by this debilitating disease. Glaucoma refers to a group of eye diseases that can cause vision loss or blindness due to damage of the optic nerve. It is one of the leading causes of irreversible blindness in the United States. High intraocular pressure (IOP) is a common risk factor for glaucoma, which over time causes stress on the optic nerve and can lead to gradual vision loss. While there currently is no available cure, the condition can be treated and ...
Source: The Catalyst - February 1, 2023 Category: Pharmaceuticals Authors: Matthew Norawong Tags: Medicines in Development Patients R & D Focus Source Type: news
Nigeria: Danger! Bitter Kola Eye Drops Won't Cure Glaucoma, Myopia and Other Eye Problems - See Doctor Instead
[Africa Check] IN SHORT: Our eyes are sensitive and easily damaged, which could lead to blindness. Don't put anything in your eyes that hasn't been approved by a qualified health professional. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - January 31, 2023 Category: African Health Source Type: news
“ I Was Blind, But Now I See ” – Celebrating Malawi’s Progress on World NTD Day
Vainesi, a former trachoma trichiasis patient, cheers in celebration knowing that trachoma has been eliminated in Malawi. Vainesi had suffered with the pain caused by trachoma for 10 years before a local disability mobiliser encouraged her to go to the hospital for treatment. By Lazarus McCarthy ChakweraLILONGWE, Jan 30 2023 (IPS) “I was blind, but now I see.” This is what Vainesi, from Salima District in Central Malawi, said after surgery to treat trachoma. A mother of three, Vainesi had been unable to work or provide for her family once the disease began to affect her eyesight.
Vainesi is one of millions of Malawians...
Source: IPS Inter Press Service - Health - January 30, 2023 Category: International Medicine & Public Health Authors: Lazarus McCarthy Chakwera Tags: Africa Development & Aid Headlines Health Poverty & SDGs Source Type: news
Mayo Clinic Minute: Protecting your eyesight from glaucoma
Glaucoma is one of the world ’s leading causes of blindness, according to the Centers for Disease Control and Prevention. January is Glaucoma Awareness Month. Half of people with glaucoma don ’t even know they have it. If you’re over 60 or have a family history of glaucoma, your risk is higher. But there is a way to protect your vision. Dr. Dave Patel, a Mayo Clinic ophthalmologist, explains one of the most important things you can do to prevent glaucoma from stealing your sight. Watch: The Mayo… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - January 26, 2023 Category: Databases & Libraries Source Type: news
New Approaches To Macular Degeneration: Test Tube Retinas
Researchers have developed a new model of the retina to study one of the leading causes of blindness: age-related macular degeneration. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - January 24, 2023 Category: Pharmaceuticals Authors: William A. Haseltine, Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma & Source Type: news
OSU, OHSU researchers use nanoparticles to target hereditary blindness
The new approach uses lipids to target the gene mutations that impair vision. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - January 11, 2023 Category: American Health Authors: Elizabeth Hayes Source Type: news
Nanotechnology may improve gene therapy for blindness
Using nanotechnology that enabled mRNA-based COVID-19 vaccines, a new approach to gene therapy may improve how physicians treat inherited forms of blindness.
A collaborative team of researchers with Oregon Health & Science University and Oregon State University have developed an approach that uses lipid nanoparticles - tiny, lab-made balls of fat - to deliver strands of messenger ribonucleic acid, or mRNA, inside the eye. (Source: World Pharma News)
Source: World Pharma News - January 11, 2023 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
Prolonged screen time may cause retinal detachment - risk of 'blindness' warns expert
Constant exposure to screens may lead to elongation of the retina, and eventually, retinal detachment. (Source: Daily Express - Health)
Source: Daily Express - Health - January 10, 2023 Category: Consumer Health News Source Type: news
Diabetics to get 'artificial pancreas' to end worry over finger-prick tests
More than 100,000 people with type 1 diabetes will be offered 'artificial pancreas' technology - which could help end the misery of amputations, kidney problems and blindness. (Source: Daily Express - Health)
Source: Daily Express - Health - January 10, 2023 Category: Consumer Health News Source Type: news
